Does TEPROTUMUMAB Cause Off label use? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Off label use have been filed in association with TEPROTUMUMAB (TEPEZZA). This represents 5.3% of all adverse event reports for TEPROTUMUMAB.
8
Reports of Off label use with TEPROTUMUMAB
5.3%
of all TEPROTUMUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Off label use From TEPROTUMUMAB?
Of the 8 reports, 1 (12.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEPROTUMUMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TEPROTUMUMAB Cause?
Deafness (21)
Endocrine ophthalmopathy (19)
Deafness bilateral (16)
Hyperglycaemia (15)
Muscle spasms (14)
Deafness neurosensory (12)
Therapy partial responder (12)
Tinnitus (11)
Diarrhoea (10)
Drug ineffective (10)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TEPROTUMUMAB Alternatives Have Lower Off label use Risk?
TEPROTUMUMAB vs TEPROTUMUMAB-TRBW
TEPROTUMUMAB vs TERAZOSIN
TEPROTUMUMAB vs TERAZOSIN\TERAZOSIN
TEPROTUMUMAB vs TERBINAFINE
TEPROTUMUMAB vs TERBINAFINE\TERBINAFINE